The Nooner

[Arbel]

$EKNL

OTC Stock Picks Newsletter Announces EKO International a Hot Penny Stock in the Healthcare Sector
PRWeb – 16 hrs ago.. .


http://www.otcstockpicks.net Newsletter Announces Details of Healthcare Diabetes Stock EKO International Corp

Stamford, CT (PRWEB) October 20, 2012
OTC Stock Picks is a premier penny stock newsletter focused on bringing investors the next hot penny stock trading opportunity, and today’s featured company EKO International, may be headed towards the Nasdaq!


The OTC Stock Picks team has been following shares of EKO International from the $0.40 range, and they continue to charge forward as a result of continuous positive news flow throughout the month of October.


The focus for investors on EKO International is product NC-Stat DPN, currently helping doctors and patients in Wal-Mart Canada clinics and managed care organizations in the US, for assisting in detecting Diabetic Peripheral Neuropathies (DPN). The annual cost of DPN has been estimated at $14 billion in the United States, where there are roughly 25 million diabetics.


The reason for the excitement related to “NC-Stat DPN”, is that there are no cures for DPN. Once a patient has DPN, it is irreversible, stays with them throughout their lifetime, and usually requires palliative and pharmaceutical treatment of pain. The key for physicians and patients is prevention, and early detection, to prevent further damage and minimizing at all costs, a lifetime of pain.


EKO’s NC-Stat DPN check device, is a point of care nerve conduction measurement tool used in the early detection of DPN. The NC-Stat DPN check is being bundled with joint venture partner NeuroVasc Clinical Inc.'s (NCI) proprietary product FREMS, which treats DPN by patented electrical frequency and duty cycle, to stimulate blood vessel re-growth and tissue regeneration in tissue that has compromised nerve and blood vessel function.


On Oct. 4, 2012, EKO International announced that NCI commenced an awareness campaign notifying health care practitioners that clinics providing treatment (FREMS) for Diabetic Peripheral Neuropathy will soon be available for their patients.


The NC-Stat DPN product is relatively new to the market having been introduced late last year. Through the end of June they’ve placed 590 devices with physicians and health care professionals in North America, including WalMart-Canada pharmacies where the test is offered as a part of a comprehensive foot examination at 100 of their stores.


Also, the large San-Antonio, Texas based managed care organization, WellMed, has adopted the technology and plans to test its patient population numbering about 100,000.


With organizations like these already behind the NC-Stat DPN, not to mention the muscle of its partner NCI, EKO International revenue is poised to grow.


More recently, on October 15, 2012, EKO International announced it has initiated the process of reducing the number of authorized common shares of the Company from One Billion (1,000,000,000) to Seventy Five Million (75,000,000). This will likely result in a broader base of investors thinking very seriously about the EKO stock in the months ahead, and could cause shares to appreciate in price.


With an anticipated outstanding share count this low, and an anticipated growing top-line, EKO could continue to be hot penny stock winner in the weeks and months ahead.


EKO International could realistically be headed to the Nasdaq!